Life-altering gene transfer therapies for serious disorders of the brain and central nervous system, including
Parkinson’s disease
,
Epilepsy
and
Huntington’s chorea
.
Recent News
Neurologix Announces Successful Phase 2 Trial of Gene Therapy for Parkinson's Disease
More
Neurologix Announces Q1 2010 Financial Results
More
Neurologix Announces Year End 2009 Results
More
CLINICAL TRIALS
Learn more
© 2010 Neurologix, Inc.
Site Map
Terms
Site design: Schenkel/Stegman
